Micro Chips Consolidated Statement of Operations for the Year Ended September 25, 2008

629 Words3 Pages
LOS Angles times Drug makers try to stall generics March 17, 2008|Melissa Healy | Times Staff Writer For the makers of brand-name prescription drugs, generic competition is about as welcome as a virus. In the first year that a generic competitor goes on the market, a brand-name drug loses on average more than half of its market share, and its price drops with each new generic company that produces a copycat, May 2005 study said. So companies that are about to face that competition have big incentives to delay the entry of new generics to the market -- and to erect obstacles to switching to the cheaper upstarts. Even a few months' delay in a generic's entry can salvage billions in revenue for the makers of a blockbuster pioneer…show more content…
Generally, legislators cite patient-safety concerns for limiting generic substitution. Last year, some 30 state legislatures considered about 60 such carve-out bills, and three passed. An additional 26 bills, including a California proposal that would limit generic substitution of epilepsy drugs, remain under consideration. Such laws "have a major freezing effect on physicians and patients and pharmacists, and that's what [the brand-name drug companies] are hoping for," Jaeger said. But physicians and medical societies that have filed citizens' petitions and lobbied for laws limiting generic substitution reject the charge that they are doing the bidding of brand-name drug companies. "We're advocates for the patient. We have no conflict of interest with the drug companies, and we're not against generics," said Dr. Flavio Vincenti, president of the American Society of Transplantation. Last September, Vincenti's medical specialist group filed a citizens' petition calling for more stringent FDA review of generic immunosuppressant drugs for transplant patients. And it has backed a wide range of state laws that would constrain generic substitution. "We just want to make sure that when they're approved
Open Document